NovoCure Ltd

NVCR chart

NovoCure Ltd news

• NovoCure Limited (NVCR) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 11, 4:20 AM EST

• FDA rejects Novocure's Optune Mya application after trial delayed brain tumor progression but failed to show a significant survival benefit

  Medical Daily · Nov 11, 2:31 AM EST

• FDA Rejects NovoCure’s Optune Mya for Lung Cancer Brain Metastases. Here's What It Means for Investors.

  fool.com · Nov 10, 2:10 PM EST

• Wedbush maintains NovoCure at Neutral, lowers price target to $19 from $20

  TradingView · Nov 10, 10:28 AM EST

• NovoCure denied FDA approval of Optune Mya for brain metastases

  TradingView · Nov 10, 10:03 AM EST

• FDA turns down Novocure’s brain metastases device

  www.lifesciencefocus.com · Nov 10, 9:17 AM EST

• NovoCure Ltd (038.DU) Seasonal returns chart

  Yahoo Finance Australia · Nov 10, 8:14 AM EST

• Novocure’s device for treating brain metastases rejected by FDA

  Medical Device Network · Nov 10, 6:00 AM EST

• Novocure denied FDA approval for Optune Mya cancer device after efficacy concerns

  Fierce Biotech · Nov 10, 5:52 AM EST

• Novocure Hits Another Setback as FDA Rejects Optune Mya

  Medical Device and Diagnostic industry · Nov 9, 4:07 PM EST

• FDA rejects Novocure's Optune Mya tumor treating fields device for lung cancer brain metastases

  MLQ.ai · Nov 9, 2:01 PM EST

• Novocure denied FDA approval for metastatic cancer treatment

  medtechdive.com · Nov 9, 11:40 AM EST

NovoCure Ltd key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-09
• 8-K8-K2026-10-29
• 10-Q10-Q2026-10-29
• 8-K8-K2026-10-01
• 8-K8-K2026-09-09
• 8-K8-K2026-09-01
• 8-K8-K2026-07-23
• 10-Q10-Q2026-07-23
• 8-K8-K2026-06-30
• 8-K8-K2026-06-18
• 8-K8-K2026-06-05
• 8-K8-K2026-04-30

About NovoCure Ltd

Ticker

NVCR (Nasdaq)

Industry

Surgical & Medical Instruments & Apparatus

Headquarters

St. Helier

Fiscal year end

December 31

SEC CIK

1645113

Frequently asked questions